- Safety and Hemodynamic Effects of Sotatercept in WHO Group 1 Pulmonary Arterial Hypertension and Group 2 CpcPH-HFpEF: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
-
Moderated Digital Poster 18‚ Clinical Science Zone 2MDP2388
Muhammad Maaz Hassan, Bahria Univ of Health Sciences, Karachi, Pakistan; Nayab Magsi, Jinnah Sindh Medical Univ, Karachi, Pakistan; Mah Rukh, Multan Medical & Dental Coll, Multan, Pakistan; Roshaan Aziz, Muhammad Hamza, Bahria Univ of Health Sciences, Karachi, Pakistan; Asia Batool, Health Service Acad, Islamabad, Pakistan; Momina Khalid, Nishtar Medical Univ, Multan, Pakistan; Abdullah Hasanat, Bahria Univ of Health Sciences, Karachi, Pakistan; Muhammad Usman Siddique, Continental Medical Coll, Lahore, Pakistan; Heba Nadeem, Bahria Univ of Health Sciences, Karachi, Pakistan; Ahmad Ali, Services Inst of Medical Sciences, Lahore, Pakistan; Maham Fatima, Weill Cornell Medical Coll, New York, NY; Danish Ali Ashraf, TruGift Health LLC, Wilmington, DE; Robert J Mentz, Duke Clinical Res Inst, Durham, NCGeneric 'disconnected' MessageCommunitiesNavigationSession TypeOnsite Viewing
Enter Note
Go to previous page in this tab
Session
